Shree Ganesh Bio-Tech (India) Limited

Company Profile

Shree Ganesh Bio-Tech (India) Limited had its IPO on under the ticker symbol 539470.

The company operates in the Other sector and Other industry. Shree Ganesh Bio-Tech (India) Limited has a staff strength of 0 employees.

Stock update

Shares of Shree Ganesh Bio-Tech (India) Limited opened at ₹0.99 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹0.91 - ₹1, and closed at ₹0.95.

This is a -3.06% slip from the previous day's closing price.

A total volume of 8,429,858 shares were traded at the close of the day’s session.

In the last one week, shares of Shree Ganesh Bio-Tech (India) Limited have slipped by -5%.

Shree Ganesh Bio-Tech (India) Limited's Key Ratios

Shree Ganesh Bio-Tech (India) Limited has a market cap of ₹2.43 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Shree Ganesh Bio-Tech (India) Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Shree Ganesh Bio-Tech (India) Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Shree Ganesh Bio-Tech (India) Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Shree Ganesh Bio-Tech (India) Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Shree Ganesh Bio-Tech (India) Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shree Ganesh Bio-Tech (India) Limited’s profitability.

Shree Ganesh Bio-Tech (India) Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Shree Ganesh Bio-Tech (India) Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹795.23 million

Total Liabilities

₹171.66 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Shree Ganesh Bio-Tech (India) Limited ended 2024 with ₹795.23 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹795.23 million while shareholder equity stood at ₹623.57 million.

Shree Ganesh Bio-Tech (India) Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹171.66 million in other current liabilities, 398624000.00 in common stock, ₹224.94 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹4.80 million and cash and short-term investments were ₹4.80 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.

Shree Ganesh Bio-Tech (India) Limited’s total current assets stands at ₹795.20 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹193.29 million compared to accounts payable of ₹164.87 million and inventory worth ₹0.00.

In 2024, Shree Ganesh Bio-Tech (India) Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Shree Ganesh Bio-Tech (India) Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹0.95

52-Week High

₹2.79

52-Week Low

₹0.85

Analyst Target Price

₹

Shree Ganesh Bio-Tech (India) Limited stock is currently trading at ₹0.95 per share. It touched a 52-week high of ₹2.79 and a 52-week low of ₹2.79. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹1.03 and 200-day moving average was ₹1.17 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.